Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Teddy Rosenbluth
Author: Teddy Rosenbluth

Written by

Teddy Rosenbluth

in

Appointments and Executive Changes, Cassava Sciences Inc, City College of New York, Clinical Trials, Drugs (Pharmaceuticals), Falsification of Data, Research, Securities and Commodities Violations
←Biden’s Student Loan Repayment Plan Blocked by Federal Appeals Court
Imagery Of A Bloodied Trump And Calls To ‘Fight’ Are Everywhere At The RNC→

More posts

  • Russell Brand’s wife says she’ll honour prison rules after message row

  • UN climate conference ends without deal as countries clash over fossil fuels, finance

  • Sheila Mangubat Dies: ’90 Day Fiancé: Before the 90 Days’ Star Was 35

  • Delta tech issue delays Atlanta-bound flights head of Thanksgiving

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube